Personal rehab program after donor bone marrow transplant
Part of Blood & lymphatic clinical trials.
This study looks at a personalized rehabilitation program for people who are eligible to receive a bone marrow transplant from a donor. The goal is to improve recovery and function after transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be eligible for an allogeneic (donor) bone marrow transplant
- You do not have any specific exclusion criteria listed for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a rehabilitation and exercise program can help people recover after an allogeneic stem cell transplant. It aims to improve your recovery and quality of life after the transplant.
This trial tests whether an adapted physical activity (tailored exercise) can help people recover after a donor stem cell transplant for blood cancers. If you’re able to participate, the program may support strength, well-being, and recovery during the transplant process.
This study tests a special exercise and education program before and after a stem cell transplant (from a donor) for people with blood cancers. The goal is to see if it helps you recover faster and feel better.
This study tests a smartphone app to help patients and doctors manage care during a bone marrow transplant. If you are planning a transplant, the app may give you clear guidance and education.
This study tests whether a guided exercise program, done mostly online, helps adults recover more quickly after a stem cell transplant for a myeloid blood disorder. It looks at physical strength, daily functioning, and overall well-being during the transplant hospital stay and the weeks after.
This study looks at how social relationships and support may affect “accelerated aging” in people soon after a bone marrow (hematopoietic cell) transplant. It may help researchers understand what kinds of support could improve health and recovery after transplant.
Hear when a new Allogeneic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.